Godavari Biorefineries Limited

This early-stage trial tested a new oral drug, MSP008-22, in 7 adults with advanced solid tumors (breast, ovarian, prostate, head and neck cancers) that had spread or could not be removed. The main goal was to find a safe dose and check for side effects. This is a first step to s…

This early-stage study tested the safety of an experimental oral drug called MSP008-22 in 64 healthy adults aged 18-50. The goal was to see if the drug is safe and how the body processes it. This is a first step toward possibly using it to control COVID-19, but it does not aim to…